MedPath

To compare the safety and efficacy of amniotic membrane transplantation and cord blood serum in cases of acute chemical injury of the eye

Phase 4
Recruiting
Conditions
Burn of eye and adnexa, part unspecified,
Registration Number
CTRI/2014/09/005067
Lead Sponsor
Dr Rajendra Prasad Centre for Ophthalmic Sciences
Brief Summary

PURPOSE: A PROSPECTIVE RANDOMIZED CONTROLLED CLINICAL TRIAL TO COMPARE THE SAFETY AND EFFICACY OF TOPICAL CORD BLOOD SERUM DROPS AND AMNIOTIC MEMBRANE TRANSPLANTATION IN ACUTE CHEMICAL INJURY

DESIGN: RANDOMIZED, CONTROLLED, CLINICAL TRIAL



PARTICIPANTS AND CONTROLS: PARTICIPANTS WITH ACUTE CHEMICAL INJURY WERE RANDOMIZED INTO 3 GROUPS



INTERVENTION: GROUP 1 TREATED WITH STANDARD TREATMENT, GROUP 2 WITH AMNIOTIC MEMBRANE GRAFT IN ADJUNCTION TO STANDARD TREATMENT, GROUP 3 TREATED WITH CORD BLOOD SERUM IN ADJUNTION TO STANDARD TREATMENT



MAIN OUTCOME MEASURES: VISUAL ACUITY, DUA’S CLASSIFICATION, CORNEAL CLARITY, LIMBAL INVOLVEMENT, EPITHELIAL DEFECT, PAIN SCORE, TEAR FILM STATUS, INTRAOCULAR PRESSURE, OTHER COMPLICATIONS

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
45
Inclusion Criteria

GRADE 3,4,5 CHEMICAL INJURY AS PER DUAS CLASSIFICATION PRESENTING WITH IN 3 WKS OF INJURIES.

Exclusion Criteria

GRADE 1,2,6 CHEMICAL INJURY AS PER DUAS CLASSIFICATION PRESENTING WITH IN 3 WKS OF INJURIES 2.IMPENDING PERFORATION OR PERFORATION AT PRESENTATION 3.NOT WILLING FOR PARTICIPATION OR FOLLOW UP.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.VISUAL ACUITY3 MONTHS
5.LIMBAL INVOLVEMENT3 MONTHS
2.DUAS CLASSIFICATION3 MONTHS
3.CORNEAL CLARITY3 MONTHS
4.EPITHELIAL DEFECT3 MONTHS
Secondary Outcome Measures
NameTimeMethod
1.PAIN SCORE2.TEAR FILM STATUS

Trial Locations

Locations (1)

Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS

🇮🇳

South, DELHI, India

Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS
🇮🇳South, DELHI, India
Dr Namrata Sharma
Principal investigator
09810856988
namrata.sharma@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.